Guj HC: Depression can be classified as serious illness

Ahmedabad (PTI) Depression can be classified as a serious illness, especially in the context of the COVID-19 pandemic, the Gujarat High Court has observed, while setting aside the cancellation of registration and admission of an engineering student by a government college for not appearing for requisite exams due to depression and suicidal thoughts.

The court issued the order on August 31 and a copy of it was made available on Thursday.

The academic performance review committee of the Surat-based Sardar Vallabhbhai National Institute of Technology (SVNIT) in October 2020 cancelled the registration and admission of the first-year B Tech (Bachelor of Technology) student, for not earning 25 credits needed for getting promoted to the next semester.

The student challenged this in the HC on the ground that he had suffered from “severe depressive episodes with suicidal ideation“, which started in January 2020 and peaked in May-June last year due to the COVID-19 pandemic situation, which is why he could not appear for the examination.

“In the facts and circumstances of the case and more particularly in the context of the currency of the pandemic period, the depressive state of mind and the depression created in the petitioner student, can be classified as serious illness,” the court of Justice N V Anjaria observed.

The depressive cycle which the petitioner suffered was during the period of COVID-19 pandemic itself. It was a period of wide-spread despondency, the court noted. PTI

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre